PGK1P2: A PDZ Protein Regulating Cell Signaling, Adhesion and Survival

Target Name: PGK1P2

NCBI ID: G5233

PGK1P2

Other Name(s): Phosphoglycerate kinase 1, pseudogene 2 | PGK2 | phosphoglycerate kinase 1, pseudogene 2

PGK1P2: A PDZ Protein Regulating Cell Signaling, Adhesion and Survival

PGK1P2, also known as phosphoglycerate kinase 1 or pseudogene 2, is a gene that encodes a protein involved in cellular signaling pathways. The protein encoded by this gene is a key regulator of various cellular processes, including cell signaling, cell adhesion, and cell survival. PGK1P2 has also been implicated in the development and progression of various diseases, including cancer. As a result, PGK1P2 has emerged as a promising drug target and a biomarker for the diagnosis and treatment of these diseases.

The protein encoded by PGK1P2 is a member of the PDZ family, which includes a variety of transmembrane proteins that play important roles in cellular signaling. PDZ proteins are characterized by a unique combination of transmembrane and intracellular domains that allow them to interact with a wide range of intracellular signaling molecules. PGK1P2 is characterized by a transmembrane domain that is involved in the formation of a PDZ domain-containing protein complex, as well as an intracellular domain that is involved in the regulation of cellular signaling pathways.

One of the most significant functions of PGK1P2 is its role in cell signaling. PGK1P2 is involved in the regulation of several intracellular signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. These pathways are involved in a wide range of cellular processes, including cell growth, differentiation, angiogenesis, and inflammation. PGK1P2 has been shown to play a critical role in the regulation of these pathways, and dysregulation of PGK1P2 has been implicated in the development and progression of various diseases.

In addition to its role in cell signaling, PGK1P2 is also involved in the regulation of cell adhesion. PGK1P2 has been shown to play a critical role in the regulation of cell-cell adhesion, and dysregulation of PGK1P2 has been implicated in the development of cancer. For example, studies have shown that PGK1P2 is involved in the regulation of tight junction formation, which is a critical step in the regulation of cell-cell adhesion. Additionally, PGK1P2 has been shown to play a role in the regulation of cell-extracellular matrix (ECM) interactions, which are also involved in cell-cell adhesion.

In addition to its role in cell signaling and cell adhesion, PGK1P2 is also involved in the regulation of cell survival. PGK1P2 has been shown to play a critical role in the regulation of cell survival, and dysregulation of PGK1P2 has been implicated in the development and progression of various diseases. For example, studies have shown that PGK1P2 is involved in the regulation of apoptosis, which is a critical mechanism of cell death that helps to remove damaged or dysfunctional cells from the body. Additionally, PGK1P2 has been shown to play a role in the regulation of cell cycle progression, which is involved in the regulation of cell growth and division.

As a result of its involvement in these critical cellular processes, PGK1P2 has been implicated in the development and progression of a wide range of diseases. For example, studies have shown that PGK1P2 is involved in the regulation of cancer cell growth and metastasis, and that dysregulation of PGK1P2 is a risk factor for the development of cancer. Additionally, PGK1P2 has been implicated in the regulation of a variety of other diseases, including neurodegenerative disorders, autoimmune diseases, and developmental diseases.

In conclusion, PGK1P2 is a gene that encodes a protein involved in

Protein Name: Phosphoglycerate Kinase 1, Pseudogene 2

The "PGK1P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PGK1P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets